What causes Type 1 Diabetes? The Environmental Determinants of Islet Autoimmunity (ENDIA) Study aims to find the cause(s) of type 1 diabetes to inform ways to prevent it. A long-term study with some results shared by Kelly who is the ENDIA coordinator, 10 years in. The exciting news is… the study has also received funding to keep doing the essential research around T1D and some possible environmental causes. Finding links to the causes of islet cell autoimmunity may well hold the key to treatments and prevention in the future.
Jaimee’s eldest son has been in this study since he was in the womb. The cord blood from pregnancy was even collected. This study is one of a kind! Listen in and please rate us on your fave podcast app… and share to help this information reach more people.
Link to ENDIA website and further information:
https://www.endia.org.au/
https://www.endia.org.au/publications/
Video updates
ENDIA Study (vimeo.com)
Type 1 Diabetes Immunotherapy Trials
ATIC (svi.edu.au)
Teplizumab: new drug to delay the onset of Type 1 Diabetes
Teplizumab (Tzield): A new drug to delay the onset of type 1 diabetes is approved in the US - Diabetes Australia
You can follow on Instagram @endiastudy
https://instagram.com/endiastudy?igshid=YmMyMTA2M2Y=
What causes Type 1 Diabetes? The Environmental Determinants of Islet Autoimmunity (ENDIA) Study aims to find the cause(s) of type 1 diabetes to inform ways to prevent it. A long-term study with some results shared by Kelly who is the ENDIA coordinator, 10 years in. The exciting news is… the study has also received funding to keep doing the essential research around T1D and some possible environmental causes. Finding links to the causes of islet cell autoimmunity may well hold the key to treatments and prevention in the future.
Jaimee’s eldest son has been in this study since he was in the womb. The cord blood from pregnancy was even collected. This study is one of a kind! Listen in and please rate us on your fave podcast app… and share to help this information reach more people.
Link to ENDIA website and further information:
https://www.endia.org.au/
https://www.endia.org.au/publications/
Video updates
ENDIA Study (vimeo.com)
Type 1 Diabetes Immunotherapy Trials
ATIC (svi.edu.au)
Teplizumab: new drug to delay the onset of Type 1 Diabetes
Teplizumab (Tzield): A new drug to delay the onset of type 1 diabetes is approved in the US - Diabetes Australia
You can follow on Instagram @endiastudy
https://instagram.com/endiastudy?igshid=YmMyMTA2M2Y=